NCT03181841View on ClinicalTrials.gov

Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

December 20, 2017

Study Completion Date

December 20, 2017

Conditions
Decision Making
Interventions
DRUG

PF-06412562

double-blind oral intake of single doses of the aforementioned drug or placebo

DRUG

Placebo

double-blind oral intake of single doses of the aforementioned drug or placebo

Trial Locations (1)

CH-8091

University Hospital Zurich, Dept. of Clinical Pharmacology and Toxicology, Zurich

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Zurich

OTHER

NCT03181841 - Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals | Biotech Hunter | Biotech Hunter